C difficile Vaccine: CLOVER Trial Shows Mixed Results

There's mixed news from Pfizer on results from the CLOVER trial of their candidate vaccine for preventing C diff infection.

Related Keywords

David Aronoff ,Centers For Disease ,Pfizer ,Department Of Medicine At Indiana University ,Vaccine Efficacy ,Medscape Medical News ,Disease Control ,Medical News ,Indiana University ,C Diff Infection ,Clostridium Difficile Infection ,Lostridium Difficile Associated Disease ,C Diff Associated Disease ,Vaccine ,Therapeutic Vaccine ,Clinical Research ,Clinical Trials ,Linical Studies ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Ealth And Med Tech ,Ealth And Medical Technology ,Hospitals ,Inpatient Care ,